Security Snapshot

MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI) Institutional Ownership

CUSIP: 56600D107

13F Institutional Holders and Ownership History from Q4 2020 to Q1 2026

Latest Period

Q1 2026

Institutions Reporting

158

Shares (Excl. Options)

121,427,233

Price

$2.83

Save this security page for your next review

Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0%
Share change
-7,561,052
Value change
-$24,258,079
Number of holders
158
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
148,167,245
SEC-reported price per share
$3.85
Insider filing price
$3.85
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors

Key facts

  • MRVI - MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share is tracked under CUSIP 56600D107.
  • 158 institutions reported positions in Q1 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 159 to 158 between Q4 2025 and Q1 2026.
  • SEC-reported value moved from $420,530,224 to $343,731,321.

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 158 institutions filings for Q1 2026.

Open SEC evidence

Security key

56600D107

Latest holder period

Q1 2026

13F holders

158

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
MRVI
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
FELDMAN STUART 7.1% +31% $32,150,185 +$7,333,001 10,337,680 +30% Stuart Feldman 31 Mar 2026
BlackRock, Inc. 5.9% $24,626,187 8,580,553 BlackRock, Inc. 30 Sep 2025
12 West Capital Management LP 4.9% -22% $22,579,206 -$5,166,145 7,260,195 -19% 12 West Capital Management LP 31 Mar 2026
MILLENNIUM MANAGEMENT LLC 4.9% $22,481,767 7,228,864 Millennium Management LLC 06 May 2026
VANGUARD GROUP INC 4.9% -23% $20,450,179 -$6,471,991 7,125,498 -24% The Vanguard Group 30 Sep 2025

As of 31 Mar 2026, 158 institutional investors reported holding 121,427,233 shares of MARAVAI LIFESCIENCES HOLDINGS, INC. - Class A Common Stock, par value $0.01 per share (MRVI). This represents 82% of the company’s total 148,167,245 outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
70%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
GTCR LLC 14% 20,150,005 0% 1.5% $57,024,514
BRAIDWELL LP 6.9% 10,240,164 +23% 0.97% $28,979,664
BlackRock, Inc. 6.3% 9,345,268 -0.35% 0% $26,447,107
12 West Capital Management LP 4.9% 7,260,195 -19% 3.5% $20,546,352
MACKENZIE FINANCIAL CORP 4.3% 6,306,425 +2.2% 0.02% $17,847,183
VANGUARD CAPITAL MANAGEMENT LLC 3.7% 5,449,702 0% 0% $15,422,657
RENAISSANCE TECHNOLOGIES LLC 2.9% 4,264,689 +0.94% 0.02% $12,069,070
Tejara Capital Ltd 2.4% 3,495,187 +16% 3.3% $9,891,379
Monaco Asset Management SAM 2.3% 3,421,020 -1.1% 3.1% $9,681,487
MORGAN STANLEY 2.2% 3,319,325 -3.7% 0% $9,393,690
Point72 Asset Management, L.P. 2.2% 3,205,496 +13% 0.02% $9,071,554
GEODE CAPITAL MANAGEMENT, LLC 1.9% 2,828,595 -0.69% 0% $8,007,237
Philosophy Capital Management LLC 1.8% 2,637,117 -15% 0.87% $7,463,041
First Eagle Investment Management, LLC 1.7% 2,524,336 +40% 0.01% $7,143,871
STATE STREET CORP 1.6% 2,428,717 +0.6% 0% $6,873,269
MARSHALL WACE, LLP 1.4% 2,081,334 +4.1% 0.01% $5,890,175
GOLDMAN SACHS GROUP INC 1.4% 2,020,329 +0.3% 0% $5,717,531
ROYCE & ASSOCIATES LP 1.2% 1,808,448 +6% 0.05% $5,117,908
GENERAL AMERICAN INVESTORS CO INC 1.2% 1,716,193 +8.3% 0.32% $4,856,826
MILLENNIUM MANAGEMENT LLC 1.1% 1,649,490 -8.2% 0% $4,668,057
JANE STREET GROUP, LLC 1.1% 1,636,145 +26% 0% $4,630,291
TWO SIGMA INVESTMENTS, LP 1.1% 1,579,840 +87% 0% $4,470,947
SYSTEMATIC FINANCIAL MANAGEMENT LP 1% 1,484,539 -2.4% 0.1% $4,201,248
CITADEL ADVISORS LLC 1% 1,484,319 +140% 0% $4,200,623
DIMENSIONAL FUND ADVISORS LP 0.96% 1,418,597 +65% 0% $4,015,154

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
22
Latest
Q1 2026
Rows shown
1-22 of 22
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q1 121,427,233 $343,731,321 -$24,258,079 $2.83 158
2025 Q4 129,359,736 $420,530,224 +$4,827,354 $3.25 159
2025 Q3 130,724,305 $375,089,033 +$4,402,400 $2.87 159
2025 Q2 129,598,496 $312,340,233 +$3,793,871 $2.41 147
2025 Q1 128,634,753 $283,834,872 -$82,865,013 $2.21 183
2024 Q4 140,252,887 $764,374,709 -$46,151,015 $5.45 182
2024 Q3 144,110,886 $1,197,438,577 -$27,583,377 $8.31 215
2024 Q2 147,440,029 $1,055,654,058 +$78,068,119 $7.16 198
2024 Q1 135,404,635 $1,173,684,706 +$20,317,754 $8.67 206
2023 Q4 134,894,754 $883,700,111 -$25,917,156 $6.55 221
2023 Q3 134,929,967 $1,348,336,074 +$67,043,720 $10.00 203
2023 Q2 126,856,268 $1,579,633,607 -$25,271,746 $12.43 219
2023 Q1 128,028,486 $1,792,250,091 +$17,285,470 $14.01 212
2022 Q4 126,849,451 $1,815,086,799 -$138,332,317 $14.31 204
2022 Q3 130,624,782 $3,334,853,905 -$30,836,051 $25.53 187
2022 Q2 131,159,603 $3,725,256,530 +$80,175,272 $28.41 202
2022 Q1 127,945,487 $4,513,679,113 -$18,120,700 $35.27 228
2021 Q4 128,005,395 $5,362,211,646 -$44,041,018 $41.90 218
2021 Q3 127,728,317 $6,268,584,283 +$685,121,082 $49.08 222
2021 Q2 114,346,717 $4,771,851,383 +$738,199,053 $41.73 194
2021 Q1 98,357,799 $3,505,428,822 +$130,695,469 $35.64 141
2020 Q4 97,446,629 $2,733,247,028 +$1,943,879,029 $28.05 114
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .